现代中西医结合杂志
現代中西醫結閤雜誌
현대중서의결합잡지
MODERN JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2009年
19期
2233-2234,2238
,共3页
张轶庠%夏宏辉%张朝霞%杨江根%罗思颖%余贵亮%张泽键
張軼庠%夏宏輝%張朝霞%楊江根%囉思穎%餘貴亮%張澤鍵
장질상%하굉휘%장조하%양강근%라사영%여귀량%장택건
前列腺特异性抗原%良性前列腺增生%前列腺癌
前列腺特異性抗原%良性前列腺增生%前列腺癌
전렬선특이성항원%량성전렬선증생%전렬선암
prostate specific antigen%benign prostate hyperplasia%prostate cancer
目的 探讨血清前列腺特异抗原(TPSA)、血清游离PSA及总PSA比值(F/TPSA)及前列腺特异性抗原密度(PSAD)对TPSA灰区(4.0~10.0μg/L)前列腺癌的诊断价值.方法 回顾性分析TPSA在灰区的82例前列腺癌患者及157例良性前列腺增生症(BPH)患者血清PSA相关检测结果 .结果 2组患者血清TPSA值无显著性差异;前列腺癌组F/T显著低于BPH组(P<0.01),PSAD显著高于BPH组(P<0.01).以F/T≤0.16、PSAD≥0.15作为诊断前列腺癌阚值的敏感性为86.7%,78.9%,特异性为63.1%,53.8%.结论TPSA>4.0 μg/L作为筛选前列腺癌的临界值存在一定缺陷;当TPSA为4.0~10.0μg/L诊断灰区时,F/T比值与PSAD对诊断前列腺癌有重要的临床意义.
目的 探討血清前列腺特異抗原(TPSA)、血清遊離PSA及總PSA比值(F/TPSA)及前列腺特異性抗原密度(PSAD)對TPSA灰區(4.0~10.0μg/L)前列腺癌的診斷價值.方法 迴顧性分析TPSA在灰區的82例前列腺癌患者及157例良性前列腺增生癥(BPH)患者血清PSA相關檢測結果 .結果 2組患者血清TPSA值無顯著性差異;前列腺癌組F/T顯著低于BPH組(P<0.01),PSAD顯著高于BPH組(P<0.01).以F/T≤0.16、PSAD≥0.15作為診斷前列腺癌闞值的敏感性為86.7%,78.9%,特異性為63.1%,53.8%.結論TPSA>4.0 μg/L作為篩選前列腺癌的臨界值存在一定缺陷;噹TPSA為4.0~10.0μg/L診斷灰區時,F/T比值與PSAD對診斷前列腺癌有重要的臨床意義.
목적 탐토혈청전렬선특이항원(TPSA)、혈청유리PSA급총PSA비치(F/TPSA)급전렬선특이성항원밀도(PSAD)대TPSA회구(4.0~10.0μg/L)전렬선암적진단개치.방법 회고성분석TPSA재회구적82례전렬선암환자급157례량성전렬선증생증(BPH)환자혈청PSA상관검측결과 .결과 2조환자혈청TPSA치무현저성차이;전렬선암조F/T현저저우BPH조(P<0.01),PSAD현저고우BPH조(P<0.01).이F/T≤0.16、PSAD≥0.15작위진단전렬선암감치적민감성위86.7%,78.9%,특이성위63.1%,53.8%.결론TPSA>4.0 μg/L작위사선전렬선암적림계치존재일정결함;당TPSA위4.0~10.0μg/L진단회구시,F/T비치여PSAD대진단전렬선암유중요적림상의의.
Objective It is to investigate the diagnosis significance of TPSA, F/TPSA and PSAD for prostate cancer (PCa) with TPSA in gray zone (4.0 - 10.0 μg/L,). Methods The correlated determined results of serum PSA of 82 patients with PCa and 157 patients with benign prostatic hypertrophy (BPH) whose PTSA was in gray zone were retrospective ana-lyzed. Results The difference in serum TPSA between the two groups was not significant(P>0.01), but F/T of Pca group was significantly lower and PSAD of PCa was significantly higher than that of BPH group(P < 0.01 ). When F/≤0.16 orPSAD≥0.15 were used as the standard to diagnose PCa, sensitivity were 86.7%, 78.9% and specificity were 63.1%, 53.8% respectively. Conclusion It is unreasonable that TPSA>4.0 μg/L is regarded as a critical value for the diagnosis of prostate carcinoma. When TPSA level is from 4.0 - 10.0 μg/L in gray zone, F/T ratio and PSAD has a significant value for diagnosing PCa.